Cardiovascular Systems Inc. (NASDAQ:CSII)’s share price shot up 6.9% on Friday . The company traded as high as $20.20 and last traded at $19.77, with a volume of 239,854 shares traded. The stock had previously closed at $18.50.

A number of brokerages recently weighed in on CSII. Needham & Company LLC restated a “buy” rating and issued a $23.00 price objective (up from $20.00) on shares of Cardiovascular Systems in a report on Wednesday, June 29th. Leerink Swann reiterated a “hold” rating on shares of Cardiovascular Systems in a research note on Friday, April 1st. Finally, Zacks Investment Research upgraded shares of Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $21.00 target price for the company in a research note on Monday, July 4th. One analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the stock. Cardiovascular Systems currently has an average rating of “Buy” and a consensus target price of $20.57.

The stock’s 50 day moving average price is $17.60 and its 200 day moving average price is $13.27. The firm’s market capitalization is $641.04 million.

Cardiovascular Systems (NASDAQ:CSII) last released its quarterly earnings data on Wednesday, May 4th. The medical device company reported ($0.31) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.54) by $0.23. The business had revenue of $44.50 million for the quarter, compared to the consensus estimate of $42.13 million. Cardiovascular Systems’s revenue for the quarter was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.34) earnings per share. On average, analysts forecast that Cardiovascular Systems Inc. will post ($1.75) earnings per share for the current year.

A hedge fund recently raised its stake in Cardiovascular Systems stock. Brown Advisory Inc. boosted its stake in shares of Cardiovascular Systems Inc. (NASDAQ:CSII) by 2.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 342,446 shares of the medical device company’s stock after buying an additional 7,010 shares during the period. Brown Advisory Inc. owned 1.05% of Cardiovascular Systems worth $5,178,000 as of its most recent SEC filing.

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.